Mirtazap-Mepha 15
Mirtazap-Mepha 15 is a medicine authorised by Swissmedic under authorisation number 61333. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 June 2011 and the authorisation is valid without a time limit. ATC code N06AX11 places the medicine in the group Psychoanaleptics.
| Authorisation number | 61333 |
|---|---|
| Name | Mirtazap-Mepha 15 |
| Full name | Mirtazap-Mepha 15, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N06AX11 |
| First authorisation | 06 June 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Mirtazap-Mepha 15, Filmtabletten | B | 06 June 2011 |
| 2 | Mirtazap-Mepha 30, Filmtabletten | B | 06 June 2011 |
| 3 | Mirtazap-Mepha 45, Filmtabletten | B | 06 June 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 6 | 10 | Tablette(n) | N06AX11 | 01.06.0. | B |
| 7 | 30 | Tablette(n) | N06AX11 | 01.06.0. | B |
| 8 | 100 | Tablette(n) | N06AX11 | 01.06.0. | B |
| 9 | 30 | Tablette(n) | N06AX11 | 01.06.0. | B |
| 10 | 100 | Tablette(n) | N06AX11 | 01.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Mirtazap-Mepha 15 authorised in Switzerland?
Yes. Mirtazap-Mepha 15 is authorised by Swissmedic under authorisation number 61333, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Mirtazap-Mepha 15 have?
Mirtazap-Mepha 15 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Mirtazap-Mepha 15?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.